3MNU
Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron containing aromatic sulfamide with mammalian isoforms I-XV
Summary for 3MNU
| Entry DOI | 10.2210/pdb3mnu/pdb |
| Related | 1CA2 |
| Descriptor | Carbonic anhydrase 2, ZINC ION, MERCURIBENZOIC ACID, ... (7 entities in total) |
| Functional Keywords | protein-inhibitor complex, lyase |
| Biological source | Homo sapiens (human) |
| Cellular location | Cytoplasm: P00918 |
| Total number of polymer chains | 1 |
| Total formula weight | 30031.30 |
| Authors | Di Fiore, A.,De Simone, G. (deposition date: 2010-04-22, release date: 2010-06-16, Last modification date: 2023-09-06) |
| Primary citation | Di Fiore, A.,Monti, S.M.,Innocenti, A.,Winum, J.Y.,De Simone, G.,Supuran, C.T. Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV. Bioorg.Med.Chem.Lett., 20:3601-3605, 2010 Cited by PubMed Abstract: We investigated the inhibition of carbonic anhydrase (CA, EC 4.2.1.1) isoforms I-XV with 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylsulfamide and other simple or sugar sulfamides, a class of less investigated CA inhibitors (CAIs). The crystal structure of the adduct of hCA II with the boron-substituted sulfamide shows the organic scaffold of this compound bound in the hydrophilic half of the active site where it makes a large number of van der Waals contacts with Ile91, Gln92, Val121, Phe131, Leu198, and Thr200. The data here reported provide further insights into sulfamide binding mechanism confirming that this zinc-binding group could be usefully exploited for obtaining new potent and selective CAIs. PubMed: 20472429DOI: 10.1016/j.bmcl.2010.04.114 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.8 Å) |
Structure validation
Download full validation report






